Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells

Kathleen A Dixon(The University of Sydney), Des R. Richardson(Griffith University)
British Journal of Cancer
January 3, 2013
Cited by 110


Related Papers